In your interest.
Online Personal Finance Magazine
No beating about the bush.
Glenn Saldanha, a serious, highly focused and confident young man, seems extremely certain about his company’s growth path.
Five years ago, Glenmark was a small formulations company, the bulk of its revenues coming from India. Today, it is a radically transformed company focused on daring new drug discovery with two molecules in clinical trials and two landmark deals with leading...